Serum Levels of Aryl Hydrocarbon Receptor Plasma Agonist Activity Are Reduced in Patients With NMOSD and Correlate With Disease Activity

Gu Y, Ibrahim BA, Gebremariam T, Alkhazraji S, Aerts R, Vanbiervliet Y, Lagrou K, Maertens J, Prattes J, Egger M, Dichtl K, Jenks JD, Hoenigl[...]

Narasaki Y, Li Z, Ong M, Siu MKM, Han SH, Chang TI, Cervantes MK, You AS, Novoa A, Le L, Nguyen DV, Kalantar-Zadeh K, Rhee[...]

Lohan S, Tiwari RK, Maslennikov I, Das Gupta K, Singh S, Parang K. Selectivity Modulation of Small Cationic Membrane-Active Cyclic Peptides with Broad-Spectrum Activity against[...]